vascugel
Cell therapyexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2006 (NCT00479180)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- srm003
- vascugel
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01806545 | Phase 2 | Mar 1, 2013 | California Institute of Renal Research, Inc., Shire |
| NCT01806584 | Phase 2 | Mar 1, 2013 | California Institute of Renal Research, Inc., Shire |
| NCT00479180 | Phase 1/Phase 2 (Phase 2) | Jul 1, 2006 | Pervasis Therapeutics, Inc |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| California Institute of Renal Research, Inc. | For profit | 2 | 0 | 1 | 2013 |
| Shire | For profit | 2 | 2 | 1 | 2013 |
| Pervasis Therapeutics, Inc | For profit | 1 | 1 | 1 | 2006 |
3 organizations
Page 1 / 1